Objective: To further evaluate whether fertility is decreased among a cohort of men with previous unilateral cryptorchidism as compared with a control group of men. Subjects and Methods: Formerly unilateral cryptorchid men who had undergone orchiopexy between the years of 1955 and 1975 at the Children’s Hospital of Pittsburgh and a control group of men who were matched for age of an unrelated surgery at the same institution were evaluated by review of medical records and by completion of a questionnaire. 359 previously cryptorchid men were identified as having attempted paternity. Of these men, 320 had information concerning preoperative testicular location and 163 for preoperative testicular size. 106 of these men had levels of testosterone, inhibin B, FSH, and LH measured, while 95 of the men had semen analyses. Results: Among men who had attempted paternity, there was no statistical difference in success of paternity between the previously unilateral group (89.7%) and the control group (93.7%). There was no difference in the mean time to conception (7.1 ± 0.7 months for the unilateral group vs. 6.9 ± 2.3 for the control group). Within the unilateral group in regard to success at paternity, no difference was found compared with the age of orchiopexy, preoperative testicular location, or preoperative testicular size. Inhibin B levels were lower among the unilateral group. FSH, LH, testosterone, sperm density, motility and morphology were not different, but considerable variation was noted within the cryptorchid group. Conclusions: In this continued evaluation of a cohort of previously cryptorchid men who had undergone unilateral orchiopexy, paternity does not appear to be significantly compromised after unilateral cryptorchidism. Unilateral cryptorchidism appears to be one of several factors contributing to infertility, similar to those found in the general population. No correlation was found between success at paternity and the age of orchiopexy, preoperative testicular size or preoperative testicular location. Inhibin B levels were lower while FSH, LH, T and sperm parameters did not differ.

Keywords:
Cryptorchidism, Paternity, Male fertility
1.
Lee PA, O’Leary LA, Songer NJ, Coughlin MT, Bellinger MF, LaPorte RE: Paternity after unilateral cyptorchidism: A controlled study. Pediatrics 1996;98:676–679.
2.
Lee PA, O’Leary LA, Songer NJ, Coughlin MT, Bellinger MF, LaPorte RE: Paternity after bilateral cryptorchidism: A controlled study. Arch Pediatr Adolesc Med 1997;151:260–263.
3.
Lee PA, Bellinger MF, Coughlin MT: Correlations among hormone levels, sperm parameters and paternity in formerly unilaterally cryptorchid men. J Urol 1998;160:1155–1157.
4.
Gross RE, Jewett TC: Surgical experience from 1,222 operations for undescended testes. JAMA 1956;160:634–641.
5.
Hand JR: Undescended testes: Report of 153 cases with evaluation of clinical findings, treatment and results followed up to 33 years. J Urol 1956;75:973–989.
6.
Barcat J: L’ectopie testiculaire: Statistiques, clinique et opératoire des Services de Chirurgie Infantile des Enfants-Malades de 1914 à 1950. Mém Acad Chir 1957;83:909–926.
7.
Atkinson PM: A follow-up study of surgically treated cryptorchid patients. J Pediatr Surg 1975;10:115–119.
8.
Lipschulz LI, Caminos-Torres R, Greenspan CS, Snyder PJ: Testicular function after orchiopexy for unilateral undescended testis. N Engl J Med 1976;295:15–18.
9.
Cendron M, Keating MA, Duckett JE, Snyder PJ: Cryptorchidism, orchiopexy and infertility – A critical long-term retrospective analysis. J Urol 1989;142:559–562.
10.
Fallon B, Kennedy TJ: Long-term follow-up fertility in cryptorchid patients. Urology 1985;25:502–504.
11.
Zuckerman Z, Rodriquez-Rigau LJ, Smith KD, Steinberger E: Frequency distribution of sperm counts in fertile and infertile males. Fertil Steril 1977;28:1310–1313.
12.
Yavetz H, Harash B, Paz G, Yogev L, Jaffa AJ, Lessing JB, Homonnai ZT: Cryptorchidism: Incidence and sperm quality in infertile men. Andrologica 1992;24:293–297.
13.
Eldrup J, Steven K: Influence of orchidopexy for cryptorchidism on subsequent fertility. Br J Surg 1980;67:269–270.
14.
Pierik FH, Vreeburg JTM, Stijen T, De Jong FH, Weber RFA: Serum inhibin B as a marker of spermatogenesis. J Clin Endocrinol Metab 1998;83:3110–3114.
© 2001 S. Karger AG, Basel
2001
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.